Medicines for malaria, tuberculosis, and AIDS are all available for children, but none are formulated specifically for the younger patient population. Recently, the World Health Organization generated an essential drug list for kids. How will they follow up on this effort? Dr. Stephen M. Spielberg, professor of pediatrics, pharmacology and toxicology at Dartmouth Medical School, and principal investigator for the Institute for Pediatric Innovation's Pediatric Pharmaceutical Reformulation Project, joins host Dr. Bill Rutenberg to discuss some of the challenges ahead: formulation, dosing, preservation, delivery and beyond.
advertisement
Worldwide Challenge: Formulating Drugs for Children
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Medicines for malaria, tuberculosis, and AIDS are all available for children, but none are formulated specifically for the younger patient population. Recently, the World Health Organization generated an essential drug list for kids. How will they follow up on this effort? Dr. Stephen M. Spielberg, professor of pediatrics, pharmacology and toxicology at Dartmouth Medical School, and principal investigator for the Institute for Pediatric Innovation's Pediatric Pharmaceutical Reformulation Project, joins host Dr. Bill Rutenberg to discuss some of the challenges ahead: formulation, dosing, preservation, delivery and beyond.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
CME/CE
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
0.25 credits
<p>Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
0.25 credits
<p>IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy</p>
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
MinuteCE®
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
0.75 credits
<p>Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?</p>
CME/CE
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
0.50 credits
<p>TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management</p>
MinuteCE®
A Practical Guide to Prescribing in HF
0.75 credits
<p>A Practical Guide to Prescribing in HF</p>
MinuteCE®
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
1.25 credits
<p>Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?